These interactions not only anchor Periplocin within the active site of HDAC10 but also likely inhibit its catalytic activity, disrupting downstream epigenetic regulatory pathway, which may contribute to tumor suppression by halting cell growth and inducing apoptosis. The gene discussed is HDAC10; the disease is neoplasm.